NEW YORK (GenomeWeb) – Genomics England said today that it has selected Icon, a provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries, as its data management partner for the 100,000 Genomes Project.
Specifically, Icon will use its data management capabilities and its clinical trials expertise to validate clinical data from 70,000 cancer and rare disease patients and their families who are participating in the UK-led effort.